Incannex Healthcare (IXHL) Other Non Operating Income (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Other Non Operating Income of $25000.0 for Q1 2026, up 102.52% year-on-year from $12344.8 in Q1 2025, and up 204.17% on a QoQ basis from -$24000.0 in Q4 2025.
Incannex Healthcare (IXHL) Other Non Operating Income (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Other Non Operating Income for 4 consecutive years, with $25000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Non Operating Income rose 102.52% year-over-year to $25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$490000.0 (up 63.32% YoY) and the FY2025 annual result came in at -$1.5 million, down 5157.14% from the prior year.
- Other Non Operating Income advanced to $25000.0 in Q1 2026 per IXHL's latest filing, from -$24000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for IXHL reached as high as $25000.0 in Q1 2026 and fell as low as -$994000.0 in Q1 2025.
- A 4-year average of -$167636.4 and a median of -$11000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2025 — Other Non Operating Income slumped 8936.36% — and 2026, when it soared 102.52%.
- Year by year, Other Non Operating Income stood at -$5000.0 in 2023, then tumbled by 6420.0% to -$326000.0 in 2024, then surged by 92.64% to -$24000.0 in 2025, then surged by 204.17% to $25000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $25000.0, -$24000.0, and -$13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 37.17 Mn | 37.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -478,000.00 |
| Mar 31, 2025 | -994,000.00 |
| Dec 31, 2024 | -326,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | -5,000.00 |
| Sep 30, 2023 | -2,000.00 |